© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
April 14, 2021
September 17, 2018
The possibility of a new antiviral class administered as a single oral dose that is well tolerated will be a welcome addition to the treatment armamentarium for #influenza. However, its use should be limited to carefully selected individuals.
February 26, 2018
Poignant study adds to the growing body of literature that points toward individualizing duration of therapy for each patient.